Interactions with Dietary Supplements
Coenzyme Q10
In double-blind trials, treatment with pravastatin and other HMG-CoA reductase inhibitors has
resulted in depleted blood levels of coenzyme Q10 (CoQ10).1 2
Supplementation with 90–100 mg CoQ10 per day has been shown to prevent reductions in
blood levels of CoQ10 due to simvastatin, another drug
in the same category as pravastatin.3 4 However, some investigators have
questioned whether it is worthwhile or necessary for individuals taking HMG-CoA reductase
inhibitors to supplement with CoQ10.5 Until more is known, people taking
pravastatin should ask a doctor about supplementation with 30–100 mg CoQ10 per day.
Fish oil
The omega-3 fatty acid EPA present in fish oil may improve the cholesterol and triglyceride-lowering effect of pravastatin. In a
preliminary trial, people with high cholesterol who had been taking pravastatin for about
three years were able to significantly lower their triglyceride levels and raise their levels
of HDL (“good”) cholesterol by supplementing with either 900 mg or 1,800 mg of EPA
for three months in addition to pravastatin.6 The authors of the study concluded
that the combination of pravastatin and EPA may prevent coronary heart disease better than
pravastatin alone.
Niacin (Vitamin B3,
Nicotinic acid)
Niacin is a vitamin used to lower cholesterol. Sixteen people with diabetes and high cholesterol were given pravastatin plus niacin
to lower cholesterol.7 Niacin was added over a two week period, to a maximum amount
of 500 mg three times per day. The combination of pravastatin plus niacin was continued for
four weeks. Compared with pravastatin, niacin plus pravastatin resulted in significantly
reduced cholesterol levels. Others have also shown that the combination of pravastatin and
niacin is more effective in lowering cholesterol levels than is pravastatin alone.8
However, large amounts of niacin taken with pravastatin might cause serious muscle disorders
(myopathy or rhabdomyolysis).9 Individuals taking pravastatin should consult a
doctor before taking niacin.
Red yeast rice
(Monascus purpureas)
A supplement containing red yeast rice (Monascus purpureas) (Cholestin®) has
been shown to effectively lower cholesterol and
triglycerides in people with moderately
elevated levels of these blood lipids.10 This extract contains small amounts of
naturally occurring HMG-CoA reductase inhibitors such as
lovastatin and should not be used by people who are currently taking lovastatin or
pravastatin.
Vitamin A
A study of 37 people with high cholesterol treated with diet and HMG-CoA reductase inhibitors
found serum vitamin A levels increased over two years of therapy.11 It remains
unclear whether this moderate increase suggests that people taking lovastatin have a
particular need to restrict vitamin A supplementation.
References
1. Mortensen SA, Leth A, Agner E, Rohde M. Dose-related decrease of serum
coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med
1997;18(suppl):S137–44.
2. Ghirlanda G, Oradei A, Manto A, et al. Evidence of plasma
CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled
study. J Clin Pharmacol 1993;33:226–9.
3. Bargossi AM, Grossi G, Fiorella PL, et al. Exogenous CoQ10
supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors.
Molec Aspects Med 1994;15(suppl):s187–93.
4. Miyake Y, Shouzu A, Nishikawa M, et al. Effect of treatment with
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic
patients. Arzneimittelforschung 1999;49:324–9.
5. Paloma’ki A, Malminiemi K, Solakivi T, Malminiemi O. Ubiquinone
supplementation during lovastatin treatment: Effect of LDL oxidation ex vivo. J Lipid
Res 1998;39:1430–7.
6. Nakamura N, Hamazaki T, Ohta M, et al. Joint effects of HMG-CoA
reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid
concentrations in patients with hyperlipidemia. Int J Clin Lab Res
1999;29:22–5.
7. Gardner SF, Marx MA, White LM, et al. Combination of low-dose niacin
and pravastatin improves the lipid profile in diabetic patients without compromising glycemic
control. Ann Pharmacother 1997;31:677–82.
8. O’Keefe JH Jr, Harris WS, Nelson J, Windsor SL. Effects of
pravastatin with niacin or magnesium on lipid levels and postprandial lipemia. Am J
Cardiol 1995;76:480–4.
9. Garnett WR. Interactions with hydroxymethylglutaryl-coenzyme A
reductase inhibitors. Am J Health Syst Pharm 1995;52:1639–45.
10. Heber D, Yip I, Ashley JM, et al. Cholesterol-lowering effects of a
proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr
1999;69:231–6.
11. Muggeo M, Zenti MG, Travia D, et al. Serum retinol levels throughout
two years of cholesterol-lowering therapy. Metabolism 1995;44:398–403.
12. Threlkeld DS, ed. Diuretics and Cardiovasculars, Antihyperlipidemic
Agents, HMG-CoA Reductase Inhibitors. In Facts and Comparisons Drug Information. St.
Louis, MO: Facts and Comparisons, Sep 1998, 172.
13. Kantola T, Kivisto KT, Neuvonen PJ. Grapefruit juice greatly
increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther
1998;63:397–402.
Copyright © 2004 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Please read the disclaimer
about the limitations of the information provided here. Do NOT rely solely on the information
in this article.
Learn more about Healthnotes, the company.
Learn more about the authors of Using
Medicines with Vitamins and Herbs
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires March 2005.